Kazim, Sabiha <br/><br/>
Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer.  [electronic resource] 

 -  Molecular cancer therapeutics  Jul 2015 
 - 1570-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1538-8514 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-15-0104  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Active Transport, Cell Nucleus--drug effects<br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Adhesion--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cyclin-Dependent Kinase Inhibitor p27--metabolism<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Female<br/>Humans<br/>Hydrazines--administration & dosage<br/>Mice, Nude<br/>Microscopy, Confocal<br/>Pancreatic Neoplasms--drug therapy<br/>Triazoles--administration & dosage<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays<br/>Gemcitabine